SIRT1 can inhibit p53 activity through deacetylation, and there is evidence to show that p53 inhibition decreases apoptosis in TECs induced by hyperglycemia, ischemia, and cisplatin [16–19]. The gene discussed is TP53; the disease is Hyperglycemia.